← Back to All Filings

Zscaler Chief Product Officer Exercises Options and Sells Shares Under Rule 10b5-1 Plan

Low SignificanceNovember 3, 2026 at 5:37:09 PM EST

Zscaler, Inc.

$ZS4CIK: 0001713683

Subscribe to track ZS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Zscaler, Inc. ($ZS) - Form 4 Filing
Insider: Geller Adam (Chief Product Officer)
Action: Option Exercise & Sale (Rule 10b5-1)
Shares Sold: 1,041 @ $238.00 ($247,758 total value)
Shares Exercised: 1,041 @ $205.61
Shares Retained: 58,167
Significance: Low

Comprehensive Analysis

Executive Summary

On November 2, 2026, Adam Geller, Chief Product Officer of Zscaler, Inc. ($ZS), executed a standard option exercise and sale transaction. The insider exercised stock options for 1,041 shares of common stock at an exercise price of $205.61 and subsequently sold the shares at $238.00 per share under a pre-established Rule 10b5-1 trading plan. The total sale proceeds amounted to $247,758.

Transaction Breakdown

  • Derivative Exercise (Code M): Exercised 1,041 options at $205.61 per share, leaving 23,959 derivative securities remaining.
  • Non-Derivative Disposition (Code S): Sold 1,041 shares at $238.00 per share pursuant to a Rule 10b5-1 plan adopted on March 20, 2026.
  • Net Post-Transaction Holding: Direct ownership stands at 58,167 shares of common stock.

Market & Significance Assessment

This transaction carries Low trading significance. It represents a routine cashless or exercise-and-sell transaction executed under a Rule 10b5-1 plan established months earlier. The volume of 1,041 shares is minor relative to both the officer's remaining holdings (58,167 direct shares) and Zscaler's daily trading volume.

Topics:#Zscaler#ZS#InsiderTrading#StockOptions#SECForm4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.